Exchange: OTC Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
0.00% $2.00
America/New_York / 10 apr 2024 @ 13:31
FUNDAMENTALS | |
---|---|
MarketCap: | 708.98 mill |
EPS: | -1.190 |
P/E: | -1.680 |
Earnings Date: | Mar 30, 2023 |
SharesOutstanding: | 354.49 mill |
Avg Daily Volume: | 0.0005 mill |
RATING 2024-04-10 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Strong Sell | |
Return On Asset: | Sell | |
DE: | Strong Buy | |
P/E: | Strong Sell | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -1.680 | sector: PE 29.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.05x |
Company: PE -1.680 | industry: PE 31.46 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 1.528 - 2.47 ( +/- 23.60%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-30 | Croyle William Russell Jr | Buy | 500 000 | Common Stock |
2019-09-24 | Croyle William Russell Jr | Sell | 0 | Common Stock |
2021-12-31 | Croyle William Russell Jr | Buy | 200 000 | Common Stock Options |
2020-04-13 | Pitts Kevin | Buy | 610 112 | Common Stock |
2019-12-20 | Pitts Kevin | Buy | 200 000 | Common Stock Options |
INSIDER POWER |
---|
100.00 |
Last 28 transactions |
Buy: 46 607 026 | Sell: 112 348 811 |